Europe Research Roundup: DSM, Novo Nordisk, Vestas

Koninklijke DSM NV

03/11/2022 07:35

Nov 3 (Reuters) - Securities analysts revised their ratings and price targets on several European
companies, including DSM, Novo Nordisk and Vestas, on Thursday. 
    HIGHLIGHTS
                 * DSM  DSMN.AS : HSBC cuts target price to EUR 130 from EUR 160 
 
                 * Novo Nordisk  NOVOb.CO : Credit Suisse raises target price to DKK 860 from
 DKK 820     
 
                 * Vestas  VWS.CO : JP Morgan cuts target price to DKK 125 from DKK 127     
 
 Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock
entries are in alphabetical order. 
                 * Auto1 Group SE  AG1G.DE : JP Morgan cuts target price to EUR 8.2 from EUR 9 
 
                 * Demant A/S  DEMANT.CO : JP Morgan cuts target price to DKK 233 from DKK 263 
 
                 * DSM  DSMN.AS : HSBC cuts target price to EUR 130 from EUR 160 
 
                 * Haleon Plc  HLN.L : Credit Suisse cuts target price to 353p from 368p 
 
                 * Inwit  INWT.MI : HSBC cuts target price to EUR 11.5 from EUR 13 
 
                 * Millennium BCP  BCP.LS : Credit Suisse raises target price to EUR 0.16 from EUR 0.15 
 
                 * Novo Nordisk  NOVOb.CO : Credit Suisse raises target price to DKK 860 from DKK 820 
 
                 * Oxford Biomedica Plc  OXB.L : Peel Hunt cuts target price to 1,170p from 1,780p 
 
                 * Vestas  VWS.CO : JP Morgan cuts target price to DKK 125 from DKK 127 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))